Stability of an extemporaneous oral liquid aprepitant formulation

被引：0
|
作者：
L. Lee Dupuis
Karen Lingertat-Walsh
Scott E. Walker
机构：
[1] The Hospital for Sick Children,Division of Hematology/Oncology, Department of Pharmacy, Research Institute
[2] The Hospital for Sick Children,Department of Pharmacy
[3] University of Toronto,Leslie Dan Faculty of Pharmacy
[4] Sunnybrook Health Sciences Center,Department of Pharmacy
来源：
Supportive Care in Cancer | 2009年 / 17卷
关键词：
Aprepitant; Suspension; Compounding;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：701 / 706
页数：5
相关论文
共 50 条
  • [1] Stability of an extemporaneous oral liquid aprepitant formulation
    Dupuis, L. Lee
    Lingertat-Walsh, Karen
    Walker, Scott E.
    SUPPORTIVE CARE IN CANCER, 2009, 17 (06) : 701 - 706
  • [2] Stability of an Alternative Extemporaneous Captopril Fast-Dispersing Tablet Formulation Versus an Extemporaneous Oral Liquid Formulation
    Pabari, Ritesh M.
    McDermott, Claire
    Barlow, James
    Ramtoola, Zebunnissa
    CLINICAL THERAPEUTICS, 2012, 34 (11) : 2221 - 2229
  • [3] Development of an extemporaneous oral liquid formulation of oxandrolone and its stability evaluation
    Garg, Alka
    Garg, Sanjay
    She, Richard Wong
    BURNS, 2011, 37 (07) : 1150 - 1153
  • [4] STABILITY OF NIZATIDINE IN EXTEMPORANEOUS ORAL LIQUID PREPARATIONS
    LANTZ, MD
    WOZNIAK, TJ
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1990, 47 (12): : 2716 - 2719
  • [5] Characterization of an extemporaneous liquid formulation of lisinopril
    Thompson, KC
    Zhao, ZX
    Mazakas, JM
    Beasley, CA
    Reed, RA
    Moser, CL
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (01) : 69 - 74
  • [6] STABILITY OF AN EXTEMPORANEOUS FORMULATION OF INJECTABLE CHOLECALCIFEROL
    BERTINO, JS
    REED, MD
    LAMBERT, PW
    HALPIN, TC
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (12): : 1932 - 1933
  • [7] Stability of flucytosine 50 mg/mL in extemporaneous oral liquid formulations
    VandenBussche, HL
    Johnson, CE
    Yun, J
    Patel, SA
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (19) : 1853 - 1855
  • [8] THE STABILITY OF AN ORAL LIQUID FORMULATION OF CYSTEAMINE
    BRODRICK, A
    BROUGHTON, HM
    OAKLEY, RM
    JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1981, 6 (01): : 67 - 70
  • [9] Extemporaneous sotalol hydrochloride oral solutions for use in paediatric cardiology: formulation and stability study
    Klovrzova, Sylva
    Zahalka, Lukas
    Kriz, Tomas
    Zahalkova, Oxana
    Matysova, Ludmila
    Sklubalova, Zdenka
    Horak, Petr
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2016, 23 (01) : 33 - 37
  • [10] Stability of Cyclophosphamide in Extemporaneous Oral Suspensions
    Kennedy, Rachel
    Groepper, Daniel
    Tagen, Michael
    Christensen, Robbin
    Navid, Fariba
    Gajjar, Amar
    Stewart, Clinton F.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (02) : 295 - 301
12345